Logo

    Dr. Sanjay Popat, Debating With Us Where the Dust Has Settled with Adjuvant Osimertinib After the ADAURA Trial | BTJ-003

    enDecember 01, 2020
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    Co-hosts Charu Aggarwal and Jack West are joined by guest expert Sanjay Popat to discuss how practice should change & open questions on molecular testing & adjuvant EGFR inhibitor osimertinib for resected early stage EGFR mutation-positive NSCLC.

    Recent Episodes from Beyond the Journal

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io